Company intelligence / Profile preview

Larix A

Ballerup, Denmark

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Larix is a leading Nordic contract research organization (CRO) that provides a comprehensive range of clinical trial services to the pharmaceutical, biotechnology, and medical device industries. Founded in 2001 and headquartered in Denmark, the company specializes in statistics, data management, clinical operations, and pharmacovigilance. Larix is recognized for its deep expertise in the Nordic regulatory landscape and its ability to support trials from Phase 1 through Phase 4. In 2021, the company was acquired by TFS HealthScience, expanding its global reach while maintaining its specialized regional focus.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Larix A.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Larix A.

Explore the full profile